These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7636873)

  • 21. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.
    Christopoulos A; Coles P; Lay L; Lew MJ; Angus JA
    Br J Pharmacol; 2001 Mar; 132(6):1281-91. PubMed ID: 11250879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips.
    Barun S; Vural IM; Dileköz E; Ercan ZS; Sarioglu Y
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):702-7. PubMed ID: 16173925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.
    Devlin MG; Christopoulos A
    J Neurochem; 2002 Mar; 80(6):1095-102. PubMed ID: 11953460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2.
    Xie XQ; Han XW; Chen JZ; Eissenstat M; Makriyannis A
    J Med Chem; 1999 Oct; 42(20):4021-7. PubMed ID: 10514272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study.
    Petitet F; Jeantaud B; Capet M; Doble A
    Biochem Pharmacol; 1997 Dec; 54(11):1267-70. PubMed ID: 9416978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2.
    Song ZH; Bonner TI
    Mol Pharmacol; 1996 May; 49(5):891-6. PubMed ID: 8622639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity.
    Tao Q; McAllister SD; Andreassi J; Nowell KW; Cabral GA; Hurst DP; Bachtel K; Ekman MC; Reggio PH; Abood ME
    Mol Pharmacol; 1999 Mar; 55(3):605-13. PubMed ID: 10051546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological properties of cannabinoid receptors in the avian brain: similarity of rat and chicken cannabinoid1 receptor recognition sites and expression of cannabinoid2 receptor-like immunoreactivity in the embryonic chick brain.
    Fowler CJ; Nilsson O; Andersson M; Disney G; Jacobsson SO; Tiger G
    Pharmacol Toxicol; 2001 Apr; 88(4):213-22. PubMed ID: 11322181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.
    Griffin G; Wray EJ; Martin BR; Abood ME
    Br J Pharmacol; 1999 Oct; 128(3):684-8. PubMed ID: 10516649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
    Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
    Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.
    Evans DM; Lake JT; Johnson MR; Howlett AC
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1271-7. PubMed ID: 8138940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.
    Romero J; Fernández-Ruiz JJ; Vela G; Ruiz-Gayo M; Fuentes JA; Ramos JA
    Drug Alcohol Depend; 1998 May; 50(3):241-9. PubMed ID: 9649978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoalkylindoles: actions on specific G-protein-linked receptors.
    Pacheco M; Childers SR; Arnold R; Casiano F; Ward SJ
    J Pharmacol Exp Ther; 1991 Apr; 257(1):170-83. PubMed ID: 1902257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
    Shim JY; Welsh WJ; Cartier E; Edwards JL; Howlett AC
    J Med Chem; 2002 Mar; 45(7):1447-59. PubMed ID: 11906286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models.
    Smith SR; Denhardt G; Terminelli C
    Eur J Pharmacol; 2001 Nov; 432(1):107-19. PubMed ID: 11734194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A.
    Petitet F; Marin L; Doble A
    Neuroreport; 1996 Feb; 7(3):789-92. PubMed ID: 8733746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
    Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
    Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V; Bisogno T; De Petrocellis L; Brandi I; Jefferson RG; Winckler RL; Davis JB; Dasse O; Mahadevan A; Razdan RK; Martin BR
    Biochem Biophys Res Commun; 2001 Feb; 281(2):444-51. PubMed ID: 11181068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
    Rinaldi-Carmona M; Barth F; Héaulme M; Shire D; Calandra B; Congy C; Martinez S; Maruani J; Néliat G; Caput D
    FEBS Lett; 1994 Aug; 350(2-3):240-4. PubMed ID: 8070571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
    Slipetz DM; O'Neill GP; Favreau L; Dufresne C; Gallant M; Gareau Y; Guay D; Labelle M; Metters KM
    Mol Pharmacol; 1995 Aug; 48(2):352-61. PubMed ID: 7651369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.